A drop named Upneeq is the first medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of acquired ptosis, a condition in which the upper eyelid droops and covers part of the eye.
Read MoreΤηλ. Επικοινωνίας
22410-20544Stay updated with the latest developments in ophthalmology, eye care tips, and clinic news
A drop named Upneeq is the first medication approved by the U.S. Food and Drug Administration (FDA) for the treatment of acquired ptosis, a condition in which the upper eyelid droops and covers part of the eye.
Read More
We are proud to announce that, for the first time in Rhodes, we successfully performed the very first glaucoma surgeries ever carried out in the Dodecanese, at our state-of-the-art Ophthalmic Day Clinic.
Read More
Patients Who Trusted Dr. Chatzinikolas Share Their Positive Experience
Read More
Participation of Dr. Konstantinos Chatzinikolas in Two Global Conferences in Vienna – Euretina and ESCRS 2018
Read More
An ophthalmologist-researcher from Massachusetts Eye and Ear performed the world’s first gene-therapy surgery for retinitis pigmentosa using Luxturna, since this treatment was approved by the FDA in December 2017.
Read More
Thank you letter to Dr. Konstantinos Chatzinikolas for the successful cataract surgery in Rhodes.
Read More
September 9, 2025
September 9, 2025
September 9, 2025